Sensitivity to CPT-11 and platinum derivatives of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncology Report

• Publication date

  2007-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/OR.17.5.1045PMID 17390039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alternating hepatic arterial infusion and systemic chemotherapy for stage IV colorectal cancer with synchronous liver metastasis.

  2006cited by this paper
• Molecular determinants of irinotecan efficacy

  2006cited by this paper
• Recurrence and 5-FU sensitivity of stage I/II node-negative breast, lung, or gastric cancer with occult neoplastic cells in lymph node sinuses.

  2006cited by this paper
• Prospective study on the recurrence/metastasis of stage II/III colorectal cancer and gastric cancer associated with occult neoplastic cells in lymph node sinuses: three-year interim results.

  2006cited by this paper
• Occult neoplastic cells and malignant micro-aggregates in lymph node sinuses: review and hypothesis.

  2005cited by this paper
• Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses.

  2005cited by this paper
• Intratumoral COX-2 Gene Expression Is a Predictive Factor for Colorectal Cancer Response to Fluoropyrimidine-Based Chemotherapy

  2005cited by this paper
• Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.

  2005cited by this paper
• Recurrence and 5-FU sensitivity of stage II/III node-positive gastric cancer with occult neoplastic cells in lymph node sinuses.

  2005cited by this paper
• Recurrence and 5-FU sensitivity of stage II/Dukes' B colorectal cancer with occult neoplastic cells in lymph node sinuses.

  2005cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Loss of Heterozygosity at the Thymidylate Synthase (TS) Locus on Chromosome 18 Affects Tumor Response and Survival in Individuals Heterozygous for a 28-bp Polymorphism in the TS Gene

  2004cited by this paper
• Predicting recurrence and metastasis of stage II/Dukes' B colorectal cancer without lymph node metastasis.

  2004cited by this paper
• Predicting recurrence and metastasis of Dukes' A primary colorectal cancer with or without proper muscle invasion.

  2004cited by this paper
• Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer.

  2004cited by this paper
• Predicting recurrence and metastasis of stage III/Dukes' C colorectal cancer with lymph node metastasis.

  2004cited by this paper
• Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.

  2003cited by this paper
• Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer.

  2003cited by this paper
• Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.

  2003cited by this paper
• Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.

  2003cited by this paper
• Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines.

  2003cited by this paper
• In vitro studies on the mechanisms of oxaliplatin resistance

  2001cited by this paper
• ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.

  2001cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Telomerase reverse transcriptase expression is increased early in the Barrett’s metaplasia, dysplasia, adenocarcinoma sequence

  2000cited by this paper
• Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells*

  1998cited by this paper
• Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil.

  1997cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• A novel method for real time quantitative RT-PCR.

  1996cited by this paper
• Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.

  1996cited by this paper
• Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries.

  1995cited by this paper
• Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

  1994cited by this paper
• The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

  1985cited by this paper
• ENZYME-LABELED ANTIBODIES FOR THE LIGHT AND ELECTRON MICROSCOPIC LOCALIZATION OF TISSUE ANTIGENS

  1967cited by this paper
• ENZYME-LABELED ANTIBODIES: PREPARATION AND APPLICATION FOR THE LOCALIZATION OF ANTIGENS

  1966cited by this paper

• Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development

  2013cites this paper
• Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy

  2013cites this paper
• Is the T1/2N1 (≤3 nodes) category actually stage IIIA (TNM)/IIIa (Japanese classification) in patients with primary colorectal cancer?

  2011cites this paper
• Stage II/III cancer of the rectosigmoid junction: an independent tumor type?

  2011cites this paper
• Efficacy of 5-FU/LV plus CPT-11 as first-line adjuvant chemotherapy for stage IIIa colorectal cancer.

  2009cites this paper
• Clinical comparison of QOL and adverse events during postoperative adjuvant chemotherapy in outpatients with node-positive colorectal cancer or gastric cancer.

  2009cites this paper
• Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.

  2008cites this paper
• Sensitivity to CPT-11 and platinum derivatives of stage II/III node-positive gastric cancer with occult neoplastic cells in lymph node sinuses

  2007cites this paper